Back
Forte Biosciences Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
36
FBRX
Forte Biosciences
Last Price:
$6.43
Seasonality Move:
-11.18%
Sell
34
CRSP
CRISPR Therapeutics AG
Last Price:
$38.28
Seasonality Move:
20.1%
Sell
36
Forte Biosciences (FBRX)
is a Sell
Is Forte Biosciences a Buy, Sell or Hold?
-
The current Forte Biosciences [FBRX] share price is $6.71. The Score for FBRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
FBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $38.27. The Score for CRSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FBRX Stock Price Chart
What is Forte Biosciences's stock price today?
-
The Forte Biosciences share price today is $6.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBRX is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $38.27The current trend is moderately bullish and CRSP is experiencing slight selling pressure.
FBRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 48.51 | Sell |
| Chaikin Money Flow: | 12642 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.8 - 7.78) | Sell |
| Bollinger Bands (100): | (6.56 - 19.6) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.07 | Buy |
| Relative Strength Index (14 RSI): | 50.42 | Buy |
| Chaikin Money Flow: | -525417 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9 - 40.02) | Buy |
| Bollinger Bands (100): | (37.22 - 46.82) | Sell |
FBRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.75 | Sell |
| 20-day SMA: | 6.53 | Buy |
| 50-day SMA: | 7.45 | Sell |
| 200-day SMA: | 10.81 | Sell |
| 8-day EMA: | 6.63 | Buy |
| 20-day EMA: | 6.68 | Buy |
| 50-day EMA: | 8.08 | Sell |
| 200-day EMA: | 11.48 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.43 | Sell |
| 20-day SMA: | 36.1 | Buy |
| 50-day SMA: | 40.71 | Sell |
| 200-day SMA: | 45.82 | Sell |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 34.63 | Buy |
| 50-day EMA: | 24.01 | Buy |
| 200-day EMA: | 8.5 | Buy |
Forte Biosciences Earnings Growth & FBRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $6.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.32 per share, and an increase next year of $1.35 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.94 per share.
Forte Biosciences Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||